News analysis: Coronavirus: The road to herd immunity

Deals with US a step forward for S. Korea's vaccine hub ambitions

But nation still faces falling vaccine supplies, low inoculation rates amid global shortage

Staff working on a Covid-19 testing kit in Gunpo, South Korea, earlier this month. Dr Jerome Kim, director-general of the Seoul-based International Vaccine Institute, said more opportunities could come for South Korea if the two other firms making mR
Staff working on a Covid-19 testing kit in Gunpo, South Korea, earlier this month. Dr Jerome Kim, director-general of the Seoul-based International Vaccine Institute, said more opportunities could come for South Korea if the two other firms making mRNA vaccines - Pfizer and CureVac - decided to follow in the footsteps of Moderna, which has a "fill and finish" production deal with Samsung Biologics. PHOTO: BLOOMBERG
New: Gift this subscriber-only story to your friends and family

South Korea and the United States signed deals on vaccine partnership when President Moon Jae-in met his US counterpart Joe Biden in Washington last week, paving the way for Seoul's ambition to become a global vaccine hub.

Experts noted, however, that South Korea still faced the fundamental problem of shrinking vaccine supplies in the country due to a global shortage.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.

A version of this article appeared in the print edition of The Straits Times on May 27, 2021, with the headline Deals with US a step forward for S. Korea's vaccine hub ambitions. Subscribe